Certara, Inc. (CERT), Mid/Small Cap AI Study of the Week
September 12, 2024
Weekly AI Study from the S&P 400 or S&P 600
Company Overview
Certara, Inc. is a prominent provider of biosimulation technology and solutions for Model-Informed Drug Development (MIDD) within the global biopharmaceutical industry. Their core offerings include advanced biosimulation platforms that utilize complex